tmh healthcare

SATURDAY 15th September 2018

Clinical utility of BRCA & HRD testing and interpretation of results

Speaker : Dr. Rajiv Sarin

watch video

Frequency and clinical significance of somatic and germline BRCA mutations

Speaker : Dr. Mithua Ghosh

watch video

Audit - Institutional BRCA data of 3 leading institutes by Dr. Amit Verma

Speaker : Dr. Amit Verma - Max Super Speciality Hospital, Saket, Delhi

watch video

Audit - Institutional BRCA data of 3 leading institutes by Dr. Rosina Ahmed

Speaker : Dr. Rosina Ahmed - Tata Medical Center, Kolkata

watch video

Audit - Institutional BRCA data of 3 leading institutes by Dr. Mithua Ghosh

Speaker : Dr. Mithua Ghosh - HCG, Banglore

watch video

Panel Discussion on clinical utility of BRCA testing

Moderator : Dr. Amit Verma

watch video

Debate - Observation versus maintenance therapy for recurrent ovarian cancer Pros and Cons

Speaker : Dr. Amit Agarwal vs Dr. Chetan Deshmukh

Moderator : Dr. Ramesh Nimmagadda

watch video

Panel Discussion on importance of platinum free interval in PSR ovarian cancer

Moderator : Dr. Ramesh Nimmagadda

watch video

Emerging data with PARPi as maintenance therapy for recurrent ovarian cancer

Speaker : Dr. Shaheenah Dawood

watch video

Debate : PARPi vs Angiogenesis inhibitors in maintenance treatment of recurrent ovarian cancer

Speaker : Dr. Bharat Bhosale vs Dr. Prasad Narayan

Moderator : Dr. Shona Nag

watch video

Panel Discussion on PARP inhibition and targeted therapy for ovarian cancer

Moderator : Dr. U D Bafna

watch video

Panel Discussion on Early HER2 positive breast cancer

Moderator : Dr. Shona Nag

watch video

Panel Discussion on metastatic HER2 positive breast cancer

Moderator : Dr. Seema Gulia

watch video

Understanding the moleculor heterogeneity of HER2 negative breast cancers

Speaker : Dr. Jaya Ghosh

watch video

Debate : Every HR+ve MBC should receive CDK 4/6 inhibitors Yes/no?

Speaker : Dr. Amol Dongre vs Dr. Sandeep Batra

Moderator : Dr. D C Doval

watch video

Overview of platinums in metastatic Triple Negative Breast Cancer(TNBC)

Speaker : Dr. Anita Ramesh

watch video

Management of metastatic TNBC beyond 1st line therapy

Speaker : Dr. Joydeep Ghosh

watch video

PARP inhibitors in management of breast cancer

Speaker : Dr. Shaheenah Dawood

watch video